We are live on ! Find out more
BLC

Brown, Lisle/Cummings Portfolio holdings

AUM $400M
1-Year Est. Return 18.79%
This Fund
S&P 500
This Quarter Est. Return
+0.35%
1 Year Est. Return
+18.79%
3 Year Est. Return
+61.76%
5 Year Est. Return
10 Year Est. Return
AUM
$335M
AUM Growth
+$5.97M
Cap. Flow
+$10.1M
Cap. Flow %
3%
Top 10 Hldgs %
27.92%
Holding
666
New
47
Increased
170
Reduced
94
Closed
28

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$1.02M
2
WRB icon
W.R. Berkley
WRB
+$1.01M
3
AMZN icon
Amazon
AMZN
+$842K
4
GD icon
General Dynamics
GD
+$368K
5
NTR icon
Nutrien
NTR
+$344K

Top Sells

Rank Stock Value
1
TROW icon
T. Rowe Price
TROW
+$501K
2
CVS icon
CVS Health
CVS
+$368K
3
BMY icon
Bristol-Myers Squibb
BMY
+$359K
4
PLTR icon
Palantir
PLTR
+$244K
5
FISV
Fiserv Inc
FISV
+$204K

Sector Composition

Rank Sector Weight
1 Technology 17.74%
2 Healthcare 14.93%
3 Financials 13.98%
4 Industrials 10.27%
5 Communication Services 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REZI icon
601
Resideo Technologies
REZI
$3.93B
$2.17K ﹤0.01%
94
-8
-8% -$188
AA icon
602
Alcoa
AA
$12.6B
$2.08K ﹤0.01%
55
MIDD icon
603
Middleby
MIDD
$6.08B
$2.03K ﹤0.01%
15
ASIX icon
604
AdvanSix
ASIX
$545M
$1.99K ﹤0.01%
70
+48
+218% +$1.45K
PATH icon
605
UiPath
PATH
$7.19B
$1.91K ﹤0.01%
150
-150
-50% -$1.98K
HSIC icon
606
Henry Schein
HSIC
$10.1B
$1.8K ﹤0.01%
26
ILMN icon
607
Illumina
ILMN
$30.3B
$1.6K ﹤0.01%
12
-13
-52% -$1.85K
DG icon
608
Dollar General
DG
$28.1B
$1.59K ﹤0.01%
21
SGMO
609
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.56K ﹤0.01%
1,525
FENY icon
610
Fidelity MSCI Energy Index ETF
FENY
$1.94B
$1.55K ﹤0.01%
65
FNDE icon
611
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$9.8B
$1.45K ﹤0.01%
50
BHVN icon
612
Biohaven
BHVN
$2.05B
$1.38K ﹤0.01%
37
SCHC icon
613
Schwab International Small-Cap Equity ETF
SCHC
$5.6B
$1.3K ﹤0.01%
38
LNG icon
614
Cheniere Energy
LNG
$53.8B
$1.29K ﹤0.01%
+6
New +$1.22K
PLD icon
615
Prologis
PLD
$131B
$1.27K ﹤0.01%
+12
New +$1.38K
SCHE icon
616
Schwab Emerging Markets Equity ETF
SCHE
$12.8B
$1.25K ﹤0.01%
47
WEC icon
617
WEC Energy
WEC
$35.2B
$1.22K ﹤0.01%
+13
New +$1.26K
GUNR icon
618
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.29B
$1.2K ﹤0.01%
33
ADPT icon
619
Adaptive Biotechnologies
ADPT
$3.95B
$1.2K ﹤0.01%
200
GLDM icon
620
SPDR Gold MiniShares Trust
GLDM
$28.8B
$1.2K ﹤0.01%
23
ORLY icon
621
O'Reilly Automotive
ORLY
$75.9B
$1.19K ﹤0.01%
+15
New +$1.21K
FDIS icon
622
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.73B
$1.17K ﹤0.01%
12
ZIMV
623
DELISTED
ZimVie
ZIMV
$1.14K ﹤0.01%
82
-29
-26% -$416
FSTA icon
624
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.42B
$1.14K ﹤0.01%
23
ALC icon
625
Alcon
ALC
$34.2B
$1.1K ﹤0.01%
13

Similar funds

Brown, Lisle/Cummings's Q4 2024 Portfolio in Review

As of Q4 2024, Brown, Lisle/Cummings held 666 positions worth $335M, up 1.8% from $329M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Brown, Lisle/Cummings deployed $10.1M of net new capital in Q4 2024, opening 47 new positions and adding to 170 existing holdings. Its largest new stake was W.R. Berkley: 16,780 shares worth $982K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was T. Rowe Price, an estimated $501K trimmed.

  • Brown, Lisle/Cummings's largest Q4 2024 buy was W.R. Berkley: 16,780 shares worth $982K.
  • Brown, Lisle/Cummings added most to Eli Lilly in Q4 2024, an estimated $1.02M increase.
  • Brown, Lisle/Cummings's biggest Q4 2024 reduction was T. Rowe Price, cutting an estimated $501K.
  • Brown, Lisle/Cummings fully exited TransUnion in Q4 2024, selling an estimated $20.9K.
  • Brown, Lisle/Cummings's ten largest holdings make up 28% of its $335M portfolio in Q4 2024.
  • Brown, Lisle/Cummings opened 47 new positions and closed 28 in Q4 2024.
  • Brown, Lisle/Cummings's portfolio value rose 1.8% quarter-over-quarter to $335M.

Based on Brown, Lisle/Cummings's 13F filing for Q4 2024, filed 27 Jan 2025.